Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription


1 Am J Hematol
3 Ann Hematol
1 Biochem Pharmacol
7 Blood
1 BMC Cancer
1 Bone Marrow Transplant
1 Cancer Lett
1 Int J Hematol
1 J Clin Oncol
2 Leuk Res
5 Leukemia
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Hematol

  1. RANAWEERA ARACHCHIGE T, Mendiburu C, Martin A, Fleury C, et al
    Clinical and biological characterization of involvement of nasal-associated lymphoid tissues in chronic lymphocytic leukemia.
    Am J Hematol. 2024 May 10. doi: 10.1002/ajh.27357.

    Ann Hematol

  2. SHI Y, Chen X, Jin H, Zhu L, et al
    Clinical prognostic value of different NPM1 mutations in acute myeloid leukemia patients.
    Ann Hematol. 2024 May 9. doi: 10.1007/s00277-024-05786.
    PubMed         Abstract available

  3. MITROVIC-AJTIC O, Zivkovic E, Suboticki T, Diklic M, et al
    Inflammation mediated angiogenesis in chronic lymphocytic leukemia.
    Ann Hematol. 2024 May 7. doi: 10.1007/s00277-024-05781.
    PubMed         Abstract available

  4. MENSHAWY NE, El-Ghonemy MS, Ebrahim MA, Fahmi MW, et al
    Aberrant ecotropic viral integration site-1 (EVI-1) and myocyte enhancer factor 2 C gene (MEF2C) in adult acute myeloid leukemia are associated with adverse t (9:22) & 11q23 rearrangements.
    Ann Hematol. 2024 May 7. doi: 10.1007/s00277-024-05779.
    PubMed         Abstract available

    Biochem Pharmacol

  5. SUN L, Rao S, Kerim K, Lu J, et al
    A chemically adjustable BMP6-IL6 axis in mesenchymal stem cells drives acute myeloid leukemia cell differentiation.
    Biochem Pharmacol. 2024;225:116262.
    PubMed         Abstract available


  6. TAMENI A, Toffalori C, Vago L
    Tricking the Trickster: Precision Medicine Approaches to Counteract Leukemia Immune Escape after Transplant.
    Blood. 2024 May 10:blood.2023019962. doi: 10.1182/blood.2023019962.
    PubMed         Abstract available

  7. LE RQ, Przepiorka D, Chen H, Shen YL, et al
    Complete Remission with Partial Hematological Recovery as a Palliative Endpoint for Treatment of Acute Myeloid Leukemia.
    Blood. 2024 May 10:blood.2023023313. doi: 10.1182/blood.2023023313.
    PubMed         Abstract available

    Transplant in AML: just follow the NPM1 guide!
    Blood. 2024;143:1881-1882.

  9. SUNG PJ
    PIKing the right target in AML.
    Blood. 2024;143:1884-1885.

  10. OTHMAN J, Potter N, Ivey A, Jovanovic J, et al
    Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission.
    Blood. 2024;143:1931-1936.
    PubMed         Abstract available

  11. GOKBUGET N, Boissel N, Chiaretti S, Dombret H, et al
    Management of ALL in adults: 2024 ELN recommendations from a European expert panel.
    Blood. 2024;143:1903-1930.
    PubMed         Abstract available

  12. GOKBUGET N, Boissel N, Chiaretti S, Dombret H, et al
    Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel.
    Blood. 2024;143:1891-1902.
    PubMed         Abstract available

    BMC Cancer

  13. YI X, Zhan H, Lyu J, Du J, et al
    Correction: A chest CT-based nomogram for predicting survival in acute myeloid leukemia.
    BMC Cancer. 2024;24:562.

    Bone Marrow Transplant

  14. BEELEN DW, Iacobelli S, Koster L, Eikema DJ, et al
    Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison.
    Bone Marrow Transplant. 2024;59:670-679.
    PubMed         Abstract available

    Cancer Lett

  15. TAN Y, Xin L, Wang Q, Xu R, et al
    FLT3-Selective PROTAC: Enhanced Safety and Increased Synergy with Venetoclax in FLT3-ITD Mutated Acute Myeloid Leukemia.
    Cancer Lett. 2024 May 3:216933. doi: 10.1016/j.canlet.2024.216933.
    PubMed         Abstract available

    Int J Hematol

  16. ITO M, Fukushima N
    Faggot cells observed in a patient with myelodysplastic syndrome with increased blasts.
    Int J Hematol. 2024;119:476-478.

    J Clin Oncol

  17. VAN DER SLUIS IM, Brigitha LJ, Fiocco M, de Groot-Kruseman HA, et al
    Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial.
    J Clin Oncol. 2024;42:1676-1686.
    PubMed         Abstract available

    Leuk Res

  18. INDRAN T, Das T, Muirhead J, O'Brien M, et al
    Donor Lymphocyte Infusion (DLI) post allogeneic stem cell transplant (allo-SCT) in Acute Myeloid Leukemia (AML) and High-Grade Myelodysplastic Syndrome (MDS). A longitudinal retrospective study using peripheral blood (PB) CD34(+) and CD3(+) donor chim
    Leuk Res. 2024;142:107504.
    PubMed         Abstract available

  19. RISUENO A, See WL, Bluemmert I, de Botton S, et al
    Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML.
    Leuk Res. 2024;140:107497.
    PubMed         Abstract available


  20. O'CONNOR KW, Kishimoto K, Kuzma IO, Wagner KP, et al
    The role of quiescent thymic progenitors in TAL/LMO2-induced T-ALL chemotolerance.
    Leukemia. 2024;38:951-962.
    PubMed         Abstract available

  21. SRINIVASAN S, Keerthivasagam S
    Mitigating immortal-time bias: exploring osteonecrosis and survival in pediatric ALL - AALL0232 trial insights.
    Leukemia. 2024;38:1187-1188.

  22. SCHULTZ LM, Jeyakumar N, Kramer AM, Sahaf B, et al
    CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results.
    Leukemia. 2024;38:963-968.
    PubMed         Abstract available

  23. WONG JC, Weinfurtner KM, Westover T, Kim J, et al
    5G2 mutant mice model loss of a commonly deleted segment of chromosome 7q22 in myeloid malignancies.
    Leukemia. 2024;38:1182-1186.
    PubMed         Abstract available

  24. YI W, Zhang J, Huang Y, Zhan Q, et al
    Ferritin-mediated mitochondrial iron homeostasis is essential for the survival of hematopoietic stem cells and leukemic stem cells.
    Leukemia. 2024;38:1003-1018.
    PubMed         Abstract available

    PLoS One

  25. MURAKAMI K, Matsunaga T, Matsuzaki T, Naruke Y, et al
    Serum bta-miRNA-375 as a potential biomarker for the early diagnosis of enzootic bovine leukosis.
    PLoS One. 2024;19:e0302868.
    PubMed         Abstract available

  26. DONG L, Dai G, Zhao J
    Impact of body mass index at diagnosis on outcomes of pediatric acute leukemia: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0302879.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.